Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Cabazitaxel (Primary) ; Topotecan
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 01 Aug 2015 Results published in the Journal of Thoracic Oncology.
- 02 Jun 2015 Results of retrospective analysis presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 10 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov.